[Efficiency of revaccination against epidemic parotitis and immunological safety].

Abstract

Seventy-eight children aged 6-7 years were subcutaneously revaccinated with L-3 live mumps vaccine. The vaccine is slightly reactogenic and completely safe. The level of antibodies increased on day 10 postvaccination in 80% of children with initially low antibody titers. Subcutaneous revaccination resulted in appearance of anti-parotitis antibodies in nasal secretions of 60% and in the saliva of 20% children, this indicating sufficiently high immunogenic activity of the vaccine.

• Authors: N V Iuminova, S K Aleksander, V A Liashchenko, E S Sidorenko
• Journal: Voprosy virusologii (Vopr Virusol) 2002 May-Jun Vol. 47 Issue 3 Pg. 44-5 ISSN: 0507-4088 [Print] Russia (Federation)
• Vernacular Title: Effektivnost' revaktsinatsii protiv épidemicheskogo parotita i immunologicheskaia bezopastost'.
• PMID: 12173437 (Publication Type: English Abstract, Journal Article)

Chemical References

• Antibodies, Viral
• Mumps Vaccine

Topics

• Antibodies, Viral (blood, immunology)
• Child
• Female
• Humans
• Injections, Subcutaneous
• Male
• Mumps (blood, immunology, prevention & control)
• Mumps Vaccine (administration & dosage, immunology)